Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
Xigris
Description:
A former brand name for drotrecogin alfa, a recombinant activated protein C drug previously used to treat severe sepsis.
Primary topic:
Sepsis Diagnosis and Treatment (47%)
Related topics:
Sepsis Diagnosis and Treatment (47%),
Blood Coagulation and Thrombosis Mechanisms (8%)
Wikidata ID:
wiki/Q412888
OpenAlex ID:
keywords/xigris
Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation
2005
·
C Green
, J Dinnes
, et al.
·
Health Technology Assessment
·
678
PDF
After Xigris, researchers look to new targets to combat sepsis
2012
·
Sarah C P Williams
·
Nature Medicine
·
60
Activated protein C in sepsis: a critical review
2008
·
Marcel Levi
·
Current Opinion in Hematology
·
47
Advances in Treating Patients With Severe Sepsis
2003
·
Ruth Kleinpell
·
Critical Care Nurse
·
44
Recombinant human activated protein C for severe sepsis in neonates
2012
·
Ranjit I Kylat
, Arne Ohlsson
·
Cochrane Database of Systematic Reviews
·
38
PDF
Activated protein C (Xigris®) treatment in sepsis: a drug in trouble
2006
·
B. Gårdlund
·
Acta Anaesthesiologica Scandinavica
·
34
Sepsis: menu of new approaches replaces one therapy for all.
2002
·
S. P Larosa
·
Cleveland Clinic Journal of Medicine
·
33
Trial failure prompts soul-searching for critical-care specialists
2012
·
Elie Dolgin
·
Nature Medicine
·
27
Repositioning of the antipsychotic drug TFP for sepsis treatment
2019
·
Jung Hwa Park
, Hyun Jin Park
, et al.
·
Journal of Molecular Medicine
·
25
PDF
Focus on sepsis
2012
·
Nature Medicine
·
25
Drug withdrawal sends critical care specialists back to basics
2011
·
Asher Mullard
·
The Lancet
·
24
Patent Law's Reproducibility Paradox.
2017
·
Jacob S Sherkow
·
PubMed
·
21
PDF
For sepsis, the drugs don't work
2012
·
The Lancet Infectious Diseases
·
The Lancet Infectious Diseases
·
21
PDF
An update on activated protein C (xigris) in the management of sepsis.
2010
·
Cesar Alaniz
·
PubMed Central
·
18
Withdrawal of ‘Xigris’ from the market: old and new lessons
2012
·
Daniele Poole
, Guido Bertolini
, et al.
·
Journal of Epidemiology & Community Health
·
16
Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adults
2005
·
Gerhard Cvirn
, Martin Koestenberger
, et al.
·
British Journal of Pharmacology
·
14
PDF
Recombinant Human Activated Protein C (xigris®)
2002
·
M Levi
, E De Jonge
, et al.
·
International Journal of Clinical Practice
·
14
PDF
Place de la protéine C activée (Xigris®) au cours du paludisme grave d'importation : bien peser le rapport bénéfice/risque
2007
·
F. Bruneel
, L. Hocqueloux
, et al.
·
Annales Françaises d Anesthésie et de Réanimation
·
12
Engineering activated protein C to maximize therapeutic efficacy
2015
·
Louise M. Quinn
, Clive Drakeford
, et al.
·
Biochemical Society Transactions
·
11
Recombinant Human Activated Protein C (Xigris) Attenuates Murine Cerulein-Induced Acute Pancreatitis Via Regulation of Nuclear Factor κB and Apoptotic Pathways
2012
·
Benoy I. Babu
, Tiziana Genovese
, et al.
·
Pancreas
·
10
Use of Drotrecogin Alfa in Necrotizing Fasciitis: A Case Report and Pharmacologic Review
2008
·
Christopher M. Bland
, James D. Frizzi
, et al.
·
Journal of Intensive Care Medicine
·
9
Y a-t-il une place pour la protéine C activée (Xigris®) dans le traitement du paludisme grave d'importation de l'adulte ?
2006
·
A. Nau
, E. Peytel
, et al.
·
Annales Françaises d Anesthésie et de Réanimation
·
9
Severe Sepsis Management
2003
·
Tom Ahrens
, Kathleen Vollman
·
Critical Care Nurse
·
8
Drotrecogin alpha (activated)
2002
·
John Lebbos
, Julia Bradsher
, et al.
·
Nature Reviews Drug Discovery
·
8
Xigris is withdrawn from the market. A 10 year odyssey.
2011
·
P M Suter
·
PubMed
·
7
Show more works
View as search
Works count:
129
Citation count:
1,306
Year
Topic
Type